Clarivate PLC is a global information services and analytics company that provides subscription-based data, insights, and workflow solutions. Operating primarily across the Academia & Government, Intellectual Property, and Life Sciences & Healthcare sectors, the company serves universities, law firms, and corporations worldwide. Clarivate is highly distinctive for its proprietary, industry-standard databases, including the Web of Science, ProQuest, and Derwent Innovation.
Financial Statements
In thousands, USD
FY 2025
FY 2024
FY 2023
FY 2022
Total Revenues
2,455,200
2,556,700
2,628,800
2,659,800
Cost of Sales
833,600
869,200
906,400
954,000
Gross Profit
1,621,600
1,687,500
1,722,400
1,705,800
Selling, General & Administrative Expenses
708,600
727,600
739,700
729,900
Depreciation & Amortization Expenses
757,200
727,000
708,300
710,500
Other Operating Expenses
84,300
508,500
1,009,100
4,191,000
Operating Profit
71,500
(275,600)
(734,700)
(3,925,600)
Non-Operating Income
265,400
278,200
277,800
63,500
Total Non-Operating Income
265,400
278,200
277,800
63,500
Income Before Provision for Income Taxes
(193,900)
(553,800)
(1,012,500)
(3,989,100)
Provision for Income Taxes
7,200
82,900
(101,300)
(28,900)
Consolidated Net Income
(201,100)
(636,700)
(911,200)
(3,960,200)
Net Income Attributable to Preferred Dividends
—
31,300
75,400
75,400
Net Income Attributable to Common Shareholders
(201,100)
(668,000)
(986,600)
(4,035,600)
Basic EPS
-0.30
-0.96
-1.47
-5.97
Diluted EPS
-0.30
-0.96
-1.47
-6.24
Basic Weighted Average Shares Outstanding
673,300
693,600
671,600
676,100
Diluted Weighted Average Shares Outstanding
673,300
693,600
671,600
678,600
Shares Outstanding
640,700
691,400
666,100
674,409
FY 2025
FY 2024
FY 2023
FY 2022
Cash and Cash Equivalents
329,200
295,200
370,700
356,800
Total Cash and Cash Equivalents
329,200
295,200
370,700
356,800
Accounts Receivable
821,700
798,300
908,300
872,100
Total Trade Receivables
821,700
798,300
908,300
872,100
Other Current Assets
159,100
151,100
183,200
166,300
Total Current Assets
1,310,000
1,244,600
1,462,200
1,395,200
Net Property, Plant & Equipment
99,300
107,100
106,800
113,400
Net Intangible Assets
8,008,100
8,441,200
9,006,600
9,437,700
Goodwill
1,566,700
1,566,600
2,023,700
2,876,500
Other Long-Term Assets
85,300
130,700
107,500
122,100
Total Assets
11,069,400
11,490,200
12,706,800
13,944,900
Accounts Payable
150,600
124,500
144,100
101,400
Accrued Expenses
419,700
428,000
441,700
485,200
Current Portion of Long-Term Debt
101,500
1,300
—
—
Current Portion of Leases
18,400
20,600
24,400
25,700
Unearned Revenue
878,600
859,100
983,100
947,500
Other Current Liabilities
—
—
6,700
—
Total Current Liabilities
1,568,800
1,433,500
1,600,000
1,559,800
Long-Term Debt
4,321,500
4,518,700
4,721,100
5,005,000
Leases
37,900
53,200
63,200
72,900
Other Long-Term Liabilities
298,300
345,800
330,200
494,700
Total Long-Term Liabilities
4,657,700
4,917,700
5,114,500
5,572,600
Total Liabilities
6,226,500
6,351,200
6,714,500
7,132,400
Preferred Stock
—
—
1,392,600
1,392,600
Common Stock
12,810,600
12,978,800
11,740,500
11,744,700
Accumulated Other Comprehensive Income
(453,100)
(526,300)
(495,300)
(665,900)
Retained Earnings
(7,514,600)
(7,313,500)
(6,645,500)
(5,658,900)
Total Common Shareholders' Equity
4,842,900
5,139,000
5,992,300
6,812,500
Total Shareholders' Equity
4,842,900
5,139,000
5,992,300
6,812,500
Total Liabilities and Shareholders' Equity
11,069,400
11,490,200
12,706,800
13,944,900
FY 2025
FY 2024
FY 2023
FY 2022
Net Income
(201,100)
(636,700)
(911,200)
(3,960,200)
Depreciation & Amortization
757,200
727,000
708,300
710,500
Share-Based Compensation Expense
63,100
59,900
109,000
93,900
Other Adjustments
5,800
521,300
898,500
3,937,000
Changes in Trade Receivables
(5,000)
92,600
(25,500)
(28,300)
Changes in Accounts Payable
22,800
(15,000)
41,200
(24,000)
Changes in Accrued Expenses
(11,300)
3,800
(44,400)
(114,400)
Changes in Unearned Revenue
(2,600)
(106,200)
20,300
(9,300)
Changes in Other Operating Activities
(400)
(100)
(52,000)
(95,900)
Cash from Operating Activities
628,500
646,600
744,200
509,300
Capital Expenditure
(263,200)
(289,100)
(242,500)
(202,900)
Payments for Business Acquisitions
—
(32,000)
(5,400)
(24,800)
Proceeds from Business Divestments
—
84,400
10,500
285,000
Cash from Investing Activities
(263,200)
(236,700)
(237,400)
57,300
Repayments of Short-Term Debt
—
—
—
(175,000)
Net Issuance / (Repayments) of Short-Term Debt
—
—
—
(175,000)
Issuance of Long-Term Debt
500,000
—
—
—
Repayments of Long-Term Debt
(600,000)
(198,100)
(300,000)
(321,500)
Net Issuance / (Repayments) of Long-Term Debt
(100,000)
(198,100)
(300,000)
(321,500)
Issuance of Common Shares
—
—
500
6,600
Repurchases of Common Shares
(224,500)
(200,000)
(100,000)
(175,000)
Net Issuance / (Repurchases) of Common Shares
(224,500)
(200,000)
(99,500)
(168,400)
Preferred Share Dividends Paid
—
(37,700)
(75,500)
(75,400)
Other Financing Activities
(18,600)
(34,300)
(21,500)
(18,900)
Cash from Financing Activities
(343,100)
(470,100)
(496,500)
(759,200)
Effect of Exchange Rate Changes on Cash and Cash Equivalents
11,800
(15,300)
3,600
(38,200)
Increase / (Decrease) in Cash, Cash Equivalents and Restricted Cash